ArticleProceedings of the National Academy of Sciences of the United States of America2016

In vivo amelioration of endogenous antitumor autoantibodies via low-dose P4N through the LTA4H/activin A/BAFF pathway.

Yu-Ling Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.